Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC12A2-DT is a human long non-coding RNA gene, classified as a divergent transcript and particularly known as LINC01184. Unlike protein-coding genes, it produces a non-protein coding RNA transcript approximately 2977 nucleotides in length[2]. SLC12A2-DT belongs to the class of long intergenic non-protein coding RNAs (lincRNAs), which regulate gene expression and cellular responses[1][6][2][8]. SLC12A2-DT is identified as a locus associated with risk of skin and soft tissue infections, and its expression patterns may change under cellular stress such as bacterial infection or certain cancers[3][2][6][7]. Although not a canonical drug target, its regulatory roles and disease associations suggest it may serve as a biomarker for infection or cancer, but no established therapeutic interventions directly target this molecule[2][6][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1184 (SLC12A2-DT).